Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.179
Filtrar
Más filtros

Intervalo de año de publicación
1.
Sex Transm Dis ; 51(10): 641-647, 2024 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-38661311

RESUMEN

ABSTRACT: We conducted a systematic literature review and meta-analysis to assess the efficacy of alternative treatments for neurosyphilis. We searched MEDLINE, Cumulative Index to Nursing and Allied Health Literature, Embase, Cochrane, Scopus, and Web of Science from database inception to September 2023, for studies in neurosyphilis that compared penicillin monotherapy with other treatments. We focused on the impact of these therapies on treatment response, but also assessed data regarding reinfection and adverse drug events. Random-effect models were used to obtain pooled mean differences. Of 3415 screened studies, 6 met the inclusion criteria for the systematic literature review. Three studies provided quantitative data that allowed for inclusion in the meta-analysis. Our analysis revealed that the efficacy of intravenous (IV) ceftriaxone 2 g daily for 10 days (51 patients) did not appear statistically different compared with IV penicillin G 18 to 24 million units daily for 10 days (185 patients) for neurosyphilis (pooled odds ratio, 2.85; 95% confidence interval, 0.41-19.56; I 2 = 49%). No statistical difference between ceftriaxone and penicillin was identified in people living with human immunodeficiency virus (HIV) (pooled odds ratio, 4.51; 95% confidence interval, 0.50-40.49; I 2 = 34%). We concluded that alternative therapy with IV ceftriaxone appears similar to penicillin, potentially expanding treatment options for neurosyphilis. Other treatment options including doxycycline warrant further study.


Asunto(s)
Antibacterianos , Neurosífilis , Humanos , Masculino , Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Ceftriaxona/administración & dosificación , Ceftriaxona/efectos adversos , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/complicaciones , Neurosífilis/complicaciones , Neurosífilis/tratamiento farmacológico , Penicilina G/administración & dosificación , Penicilina G/efectos adversos , Penicilinas/administración & dosificación , Penicilinas/efectos adversos , Resultado del Tratamiento
2.
Eur J Clin Microbiol Infect Dis ; 40(10): 2145-2152, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33942165

RESUMEN

The objective of our study was to evaluate by pharmacokinetic/pharmacodynamic (PK/PD) analysis, if the antimicrobials used for the treatment of invasive pneumococcal disease (IPD) in adults, including meningitis, are adequate considering the susceptibility profile of S. pneumoniae in Spain after the implantation of PVC13 vaccine. Pharmacokinetic parameters of benzylpenicillin and cefotaxime were obtained from the literature, and susceptibility data of invasive S. pneumoniae strains recovered in 2017 (post-PCV13 vaccination period) were provided by the Public Health Regional Laboratory of Madrid. We have also studied levofloxacin because it is used to treat pneumococcal pneumonia previously to be diagnosed as bacteremic pneumonia. Monte Carlo simulation was used to estimate the probability of target attainment (PTA) and the cumulative fraction of response (CFR). All doses of benzylpenicillin except 2 mU q6h provide a high probability of treatment success for MIC values ≤ 1 mg/L; 4 mU q4h is even useful for MIC values up to 4 mg/L. This high dose, used for the treatment of meningitis, also provides high probability of treatment success for MIC ≤ 0.5 mg/L. At the susceptibility EUCAST breakpoint (≤ 0.5 mg/L), cefotaxime provides a high rate of PD target achievement, even at the lowest dose (1 g q8h). For meningitis, 2 g q6h ensures probabilities of target attainment ≥90% for MIC up to 1 mg/L. Our study confirms that after the implementation of PCV13 vaccine, the treatment with benzylpenicillin and cefotaxime provides high probability of the therapy success of IPD, including meningitis.


Asunto(s)
Antibacterianos/farmacocinética , Infecciones Neumocócicas/tratamiento farmacológico , Vacunas Neumococicas/administración & dosificación , Streptococcus pneumoniae/efectos de los fármacos , Adulto , Antibacterianos/administración & dosificación , Cefotaxima/administración & dosificación , Ensayos Clínicos como Asunto , Humanos , Levofloxacino/administración & dosificación , Penicilina G/administración & dosificación , Infecciones Neumocócicas/microbiología , España , Streptococcus pneumoniae/fisiología
3.
J Am Acad Dermatol ; 82(1): 17-28, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30986474

RESUMEN

The methods used for the laboratory diagnosis of syphilis include direct detection of Treponema pallidum subspecies pallidum and serologic testing. Serologic testing relies on both nontreponemal and treponemal tests. In newly developed reverse-sequence screening algorithms, treponemal tests are performed before nontreponemal tests. The management of syphilis requires appropriate staging, treatment, and follow-up of patients along with the prompt reporting of infections to public health authorities to assist with prevention and control efforts. Benzathine penicillin G remains the treatment of choice for all stages of syphilis. Screening of populations at higher risk for syphilis is recommended by the US Centers for Disease Control and Prevention, the US Preventive Services Task Force, and the World Health Organization. The second article in this continuing medical education series reviews the testing for and the management of sexually acquired syphilis.


Asunto(s)
Penicilina G/administración & dosificación , Enfermedades de Transmisión Sexual/diagnóstico , Serodiagnóstico de la Sífilis/métodos , Sífilis/diagnóstico , Sífilis/epidemiología , Treponema pallidum/patogenicidad , Técnicas de Laboratorio Clínico , Diagnóstico Precoz , Educación Médica Continua , Humanos , Incidencia , Masculino , Prevención Primaria/organización & administración , Enfermedades de Transmisión Sexual/tratamiento farmacológico , Enfermedades de Transmisión Sexual/epidemiología , Sífilis/tratamiento farmacológico , Estados Unidos/epidemiología
4.
Biol Pharm Bull ; 43(11): 1669-1677, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33132311

RESUMEN

Prostaglandin (PG) D2 is a lipid mediator, and in the brain, overproduction of PGD2 is reportedly involved in the progression and exacerbation of neuroinflammation. The objective of this study was to elucidate PGD2 efflux transport, under normal and inflammatory conditions, across the blood-brain barrier (BBB), which is formed by brain capillaries. Elimination of [3H]PGD2 across the BBB of normal and lipopolysaccharide (LPS)-induced inflammatory rats was examined by the intracerebral microinjection technique. After intracerebral injection, the percentage of [3H]PGD2 remaining in the ipsilateral cerebrum decreased with time, with a half-life of 13 min. This [3H]PGD2 elimination across the BBB was significantly inhibited by the co-administration of unlabeled PGD2, which suggests carrier-mediated PGD2 efflux transport at the BBB. In isolated rat brain capillaries, mRNA expression of organic anion transporter (Oat) 3, organic anion-transporting polypeptide (Oatp) 1a4, and multidrug resistance-associated protein (Mrp) 4 was observed. In addition, co-administration of substrates/inhibitors for Oat3, Oatp1a4, and/or Mrp4, such as benzylpenicillin and cefmetazole, reduced [3H]PGD2 elimination across the BBB. Data suggest that Oat3 and Mrp4, but not Oatp1a4 are involved in PGD2 elimination across the BBB, as Oatp1a4-expressing Xenopus (X.) oocytes did not show the significant [3H]PGD2 uptake compared with water-injected X. oocytes. In LPS-treated rats, [3H]PGD2 elimination across the BBB and mRNA expression levels of Oat3 and Mrp4 were significantly decreased. Our data suggest that Oat3- and Mrp4-mediated PGD2 elimination across the BBB is attenuated under inflammatory conditions.


Asunto(s)
Barrera Hematoencefálica/patología , Encefalopatías/inmunología , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Transportadores de Anión Orgánico Sodio-Independiente/metabolismo , Prostaglandina D2/metabolismo , Animales , Barrera Hematoencefálica/efectos de los fármacos , Barrera Hematoencefálica/inmunología , Encefalopatías/patología , Cefmetazol/administración & dosificación , Modelos Animales de Enfermedad , Regulación hacia Abajo/inmunología , Humanos , Inflamación/inmunología , Inflamación/patología , Lipopolisacáridos/administración & dosificación , Lipopolisacáridos/inmunología , Masculino , Microinyecciones , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/antagonistas & inhibidores , Oocitos , Transportadores de Anión Orgánico Sodio-Independiente/antagonistas & inhibidores , Penicilina G/administración & dosificación , Ratas , Xenopus laevis
5.
J Vet Pharmacol Ther ; 43(4): 319-324, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32212341

RESUMEN

The aim of this study was to determine the effect of benzylpenicillin on the pharmacokinetics of acyclovir in red-eared slider turtles (Trachemys scripta elegans). Six clinically healthy red-eared slider turtles weighing 400 and 580 g were used for the study. Acyclovir (40 mg/kg) and benzylpenicillin (30 mg/kg) were administered intravenously to turtles. In the study, the cross-pharmacokinetic design (2 × 2) with a 30-day washout period was performed in two periods. Plasma concentrations of acyclovir were assayed using the high-performance liquid chromatography with fluorescence detection. Pharmacokinetic parameters were calculated by two-compartment open pharmacokinetic model. Following the administration of acyclovir alone, elimination half-life (t1/2 ß ), area under the plasma concentration-time curve (AUC), total clearance (ClT ), and volume of distribution at steady-state (Vdss ) were 20.12 hr, 1,372 hr * µg/mL, 0.03 L hr-1  kg-1 , and 0.84 L/kg, respectively. Benzylpenicillin administration increased t1/2 ß , AUC, and Vdss while decreased ClT of acyclovir. These results showed that benzylpenicillin changed the pharmacokinetics of acyclovir following simultaneous administration in turtles. However, further research is needed to determine molecular mechanism of interaction in turtle.


Asunto(s)
Aciclovir/farmacocinética , Antibacterianos/farmacocinética , Antivirales/farmacocinética , Penicilina G/farmacocinética , Tortugas/metabolismo , Aciclovir/administración & dosificación , Animales , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Antivirales/administración & dosificación , Antivirales/sangre , Área Bajo la Curva , Estudios Cruzados , Interacciones Farmacológicas , Semivida , Inyecciones Intravenosas/veterinaria , Penicilina G/administración & dosificación , Tortugas/sangre
6.
Int J Mol Sci ; 21(5)2020 Mar 04.
Artículo en Inglés | MEDLINE | ID: mdl-32143463

RESUMEN

This paper aims to validate if intrapancreatic injection of penicillin G can enhance hardness and suture holding capacity (SHC) of the pancreas through prompting the fibrosis process. Soft pancreatic texture is constantly mentioned as one of the most contributory predictors of postoperative pancreatic fistula (POPF). Soft pancreas has poor SHC and higher incidence of parenchymal tearing, frequently leading to POPF. From a library of 114 antibiotic compounds, we identified that penicillin G substantially enhanced pancreatic hardness and SHC in experimental mice. Specifically, we injected penicillin G directly into the pancreas. On determined dates, we measured the pancreatic hardness and SHC, respectively, and performed molecular and histological examinations for estimation of the degree of fibrosis. The intrapancreatic injection of penicillin G activated human pancreatic stellate cells (HPSCs) to produce various fibrotic materials such as transforming growth factor-ß1 (TGF-ß1) and metalloproteinases-2. The pancreatic hardness and SHC were increased to the maximum at the second day after injection and then it gradually subsided demonstrating its reversibility. Pretreatment of mice with SB431542, an inhibitor of the TGF-ß1 receptor, before injecting penicillin G intrapancreatically, significantly abrogated the increase of both pancreatic hardness and SHC caused by penicillin G. This suggested that penicillin G promotes pancreatic fibrosis through the TGF-ß1 signaling pathway. Intrapancreatic injection of penicillin G promotes pancreatic hardness and SHC by enhancing pancreatic fibrosis. We thus think that penicillin G could be utilized to prevent and minimize POPF, after validating its actual effectiveness and safety by further studies.


Asunto(s)
Procedimientos Quirúrgicos del Sistema Digestivo/efectos adversos , Páncreas/efectos de los fármacos , Páncreas/cirugía , Fístula Pancreática/prevención & control , Penicilina G/administración & dosificación , Complicaciones Posoperatorias/prevención & control , Animales , Antibacterianos/administración & dosificación , Benzamidas/farmacología , Dioxoles/farmacología , Modelos Animales de Enfermedad , Fibrosis , Humanos , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Ratones , Ratones Endogámicos BALB C , Fístula Pancreática/etiología , Células Estrelladas Pancreáticas/efectos de los fármacos , Células Estrelladas Pancreáticas/metabolismo , Periodo Posoperatorio , Receptores de Factores de Crecimiento Transformadores beta/antagonistas & inhibidores , Factor de Crecimiento Transformador beta1/metabolismo
7.
JAAPA ; 33(8): 44-47, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32740114

RESUMEN

Syphilis is on the rise in every age and ethnicity group across the United States. The rate of congenital syphilis has started to rise as well, increasing the need for syphilis screening before pregnancy occurs. Raising awareness for syphilis screening, especially among sexually active women, is important, as the implications of this disease have lifelong effects for mother and child.


Asunto(s)
Tamizaje Masivo/métodos , Complicaciones Infecciosas del Embarazo/prevención & control , Sífilis Congénita/prevención & control , Sífilis/diagnóstico , Sífilis/prevención & control , Adolescente , Adulto , Antitreponémicos/administración & dosificación , Femenino , Humanos , Masculino , Penicilina G/administración & dosificación , Penicilina G Benzatina/administración & dosificación , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/microbiología , Sífilis/tratamiento farmacológico , Sífilis/microbiología , Serodiagnóstico de la Sífilis/métodos , Treponema pallidum/aislamiento & purificación , Treponema pallidum/patogenicidad , Adulto Joven
8.
J Trop Pediatr ; 65(1): 71-77, 2019 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-29660106

RESUMEN

Implementing the World Health Organization (WHO) recommendations on home-based management of pneumonia with chest indrawing is challenging in many settings. In Papua New Guinea, 120 children presenting with the WHO definition of pneumonia were screened for danger signs, comorbidities and hypoxaemia using pulse oximetry; 117 were appropriate for home care. We taught mothers about danger signs and when to return, using structured teaching materials and a video. The children were given a single dose of intramuscular benzylpenicillin, then sent home on oral amoxicillin for 5 days, with follow-up at Days 2 and 6. During the course of treatment, five (4%) of the 117 children were admitted and 15 (13%) were lost to follow-up. There were no deaths. Treating children with pneumonia with chest indrawing but no danger signs is feasible as long as safeguards are in place-excluding high-risk patients, checking for danger signs and hypoxemia and providing education for mothers and follow-up.


Asunto(s)
Amoxicilina/uso terapéutico , Hospitales Generales/estadística & datos numéricos , Pacientes Ambulatorios/estadística & datos numéricos , Penicilina G/uso terapéutico , Neumonía/tratamiento farmacológico , Tórax/fisiopatología , Administración Oral , Amoxicilina/administración & dosificación , Niño , Preescolar , Estudios de Factibilidad , Femenino , Humanos , Hipoxia/terapia , Lactante , Inyecciones Intramusculares , Masculino , Oximetría , Papúa Nueva Guinea/epidemiología , Penicilina G/administración & dosificación , Neumonía/diagnóstico , Neumonía/epidemiología , Guías de Práctica Clínica como Asunto , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Organización Mundial de la Salud
9.
JAMA ; 332(4): 331-332, 2024 07 23.
Artículo en Inglés | MEDLINE | ID: mdl-38874952
10.
J Vet Pharmacol Ther ; 42(4): 461-475, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31012501

RESUMEN

Penicillin G is widely used in food-producing animals at extralabel doses and is one of the most frequently identified violative drug residues in animal-derived food products. In this study, the plasma pharmacokinetics and tissue residue depletion of penicillin G in heavy sows after repeated intramuscular administrations at label (6.5 mg/kg) and 5 × label (32.5 mg/kg) doses were determined. Plasma, urine, and environmental samples were tested as potential antemortem markers for penicillin G residues. The collected new data and other available data from the literature were used to develop a population physiologically based pharmacokinetic (PBPK) model for penicillin G in heavy sows. The results showed that antemortem testing of urine provided potential correlation with tissue residue levels. Based on the United States Department of Agriculture Food Safety and Inspection Service action limit of 25 ng/g, the model estimated a withdrawal interval of 38 days for penicillin G in heavy sows after 3 repeated intramuscular injections at 5 × label dose. This study improves our understanding of penicillin G pharmacokinetics and tissue residue depletion in heavy sows and provides a tool to predict proper withdrawal intervals after extralabel use of penicillin G in heavy sows, thereby helping safety assessment of sow-derived meat products.


Asunto(s)
Antibacterianos/farmacocinética , Peso Corporal , Modelos Biológicos , Penicilina G/farmacocinética , Porcinos/sangre , Animales , Antibacterianos/administración & dosificación , Simulación por Computador , Relación Dosis-Respuesta a Droga , Residuos de Medicamentos , Femenino , Penicilina G/administración & dosificación , Porcinos/metabolismo , Porcinos/orina
11.
Microb Pathog ; 118: 220-229, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29578067

RESUMEN

While antimicrobials are cost-effective tools for prevention and treatment of infectious disease, the impact of their use on potentially beneficent mucosal microbial communities of growing pigs has not been widely explored. The objective of this study was to characterize the impact of parenteral antibiotics administration on the composition and diversity of the resident fecal microbiota in growing pigs. Five antimicrobial treatment groups, each consisting of four, eight-week old piglets, were administered one of the antimicrobials; Ceftiofur Crystalline free acid (CCFA), Ceftiofur hydrochloride (CHC), Oxytetracycline (OTC), Procaine Penicillin G (PPG) and Tulathromycin (TUL) at label dose and route. Individual fecal swabs were collected immediately before antimicrobial administration (control = day 0), and again on days 1, 3, 7, and 14 after dosing. Genomic DNA was extracted, and the V1-V3 hypervariable region of 16S rRNA gene was amplified and sequenced using Illumina Miseq-based sequencing. Across all groups, the most abundant phyla were Firmicutes, Bacteroidetes, and Proteobacteria. Linear discriminant analysis and stacked area graphs, showed a pronounced, antimicrobial-dependent shift in the composition of fecal microbiota over time from day 0. By day 14, the fecal microbial compositions of the groups receiving CHC and TUL had returned to a distribution that closely resembled that observed on day 0, but differences were still evident. In contrast, animals that received PPG, OTC and CCFA, showed a tendency towards a balanced homeostatic microbiota structure on day 7, but appeared to deviate away from the day 0 composition by day 14. Based on our results, the observed changes in fecal microbiota showed antimicrobial-specific variation in both duration and extent. Understanding the impact of these important antimicrobial-induced changes will be a critical step in optimizing the use of antimicrobials in health management programs in the swine industry.


Asunto(s)
Antiinfecciosos/administración & dosificación , Antiinfecciosos/farmacología , Biodiversidad , Heces/microbiología , Microbiota/efectos de los fármacos , Porcinos/crecimiento & desarrollo , Porcinos/microbiología , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Cefalosporinas/administración & dosificación , Cefalosporinas/farmacología , ADN Bacteriano/análisis , ADN Bacteriano/genética , Disacáridos/administración & dosificación , Disacáridos/farmacología , Combinación de Medicamentos , Compuestos Heterocíclicos/administración & dosificación , Compuestos Heterocíclicos/farmacología , Consorcios Microbianos/efectos de los fármacos , Consorcios Microbianos/genética , Datos de Secuencia Molecular , Oxitetraciclina/administración & dosificación , Oxitetraciclina/farmacología , Penicilina G/administración & dosificación , Penicilina G/farmacología , Penicilina G Procaína/administración & dosificación , Penicilina G Procaína/farmacología , Filogenia , ARN Ribosómico 16S/genética , Factores de Tiempo
12.
Eur J Clin Microbiol Infect Dis ; 37(9): 1761-1775, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29961165

RESUMEN

There is consensus that definitive therapy for infections with H. influenzae should include antimicrobial agents with clinical breakpoints against the bacterium. In Scandinavia, benzylpenicillin is the recommended empirical treatment for community-acquired pneumonia (CAP) except in very severe cases. However, the effect of benzylpenicillin on H. influenzae infections has been debated. The aim of this study was to compare the outcomes of patients given benzylpenicillin with patients given wide-spectrum beta-lactams (WSBL) as empirical treatment of lower respiratory tract H. influenzae infections requiring hospital care. We identified 481 adults hospitalized with lower respiratory tract infection by H. influenzae, bacteremic and non-bacteremic. Overall, 30-day mortality was 9% (42/481). Thirty-day mortality, 30-day readmission rates, and early clinical response rates were compared in patients receiving benzylpenicillin (n = 199) and a WSBL (n = 213) as empirical monotherapy. After adjusting for potential confounders, empirical benzylpenicillin treatment was not associated with higher 30-day mortality neither in a multivariate logistic regression (aOR 2.03 for WSBL compared to benzylpenicillin, 95% CI 0.91-4.50, p = 0.082), nor in a propensity score-matched analysis (aOR 2.14, 95% CI 0.93-4.92, p = 0.075). Readmission rates did not significantly differ between the study groups, but early clinical response rates were significantly higher in the WSBL group (aOR 2.28, 95% CI 1.21-4.31, p = 0.011), albeit still high in both groups (84 vs 81%). In conclusion, despite early clinical response rates being slightly lower for benzylpenicillin compared to WSBL, we found no support for increased mortality or readmission rates in patients empirically treated with benzylpenicillin for lower respiratory tract infections by H. influenzae.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Haemophilus/tratamiento farmacológico , Haemophilus influenzae/efectos de los fármacos , Penicilina G/uso terapéutico , Infecciones del Sistema Respiratorio/tratamiento farmacológico , beta-Lactamas/uso terapéutico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/administración & dosificación , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Niño , Preescolar , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/mortalidad , Femenino , Infecciones por Haemophilus/epidemiología , Infecciones por Haemophilus/microbiología , Infecciones por Haemophilus/mortalidad , Hospitalización , Humanos , Lactante , Recién Nacido , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Penicilina G/administración & dosificación , Neumonía/tratamiento farmacológico , Neumonía/microbiología , Puntaje de Propensión , Infecciones del Sistema Respiratorio/microbiología , Estudios Retrospectivos , Suecia/epidemiología , Adulto Joven , beta-Lactamas/administración & dosificación
13.
J Infect Chemother ; 24(10): 856-859, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29705391

RESUMEN

Some infectious diseases, such as infective endocarditis, osteomyelitis, and abscesses, require treatment with long-term intravenous antimicrobial treatment. Therefore, the patient is required to stay in the hospital to receive therapy, which lowers their quality of life. Establishing an outpatient parenteral antimicrobial therapy (OPAT) by continuous infusion pump is desired in Japan to overcome these issues. However, the 24-h stability of antimicrobial agents dissolved in infusion solutions is unclear. Thus, we investigated the stability of antimicrobial agents in five different infusion solutions in a clinical setting. Benzylpenicillin potassium (PCG) and ampicillin (ABPC) were dissolved separately in five different infusion solutions and kept at 25 or 31.1 °C for 24 h. The residual ratios were determined by high-performance liquid chromatography (HPLC). Dissolved PCG in acetate ringer solution remained stable for 24 h at temperatures of 25 and 31.1 °C (101.7 ± 1.4% and 92.9 ± 1.3%, respectively). In addition, the PCG solution did not adsorb onto the elastomeric infusion pump after 24 h at 31.1 °C. PCG dissolved in acetate ringer solution was also stable for 10 days after being kept in an elastomeric infusion pump at 4 °C (99.7 ± 0.5%). ABPC was unstable in all of the tested infusion solutions and temperatures. Based on our results, PCG in acetate ringer solution can be used in OPAT with continuous infusion pumps.


Asunto(s)
Ampicilina/administración & dosificación , Ampicilina/química , Antibacterianos/administración & dosificación , Antibacterianos/química , Bombas de Infusión , Penicilina G/administración & dosificación , Penicilina G/química , Estabilidad de Medicamentos , Elastómeros , Humanos , Concentración de Iones de Hidrógeno , Infusiones Intravenosas , Soluciones Isotónicas/administración & dosificación , Soluciones Isotónicas/química , Japón , Temperatura , Factores de Tiempo
14.
J Infect Chemother ; 24(10): 812-814, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30006248

RESUMEN

The 1,3-beta-D-Glucan (BDG) assay is widely used for the diagnosis of fungal infections, especially in patients with hematologic malignancies. Some antimicrobials have been reported to cause false-positive results for BDG, but there has been no report on the effect of penicillin G (PCG) on BDG levels. We experienced a patient who developed false-positive BDG elevation during the administration of PCG for osteomyelitis due to Streptococcus pneumoniae infection. The serum BDG level increased up to 81.0 pg/ml during the continuous administration of PCG at 24 million units per day. However, chest and paranasal CT scan showed no evidence of fungal infection. The BDG level decreased to 38.0 pg/ml at 14 hours after the discontinuation of PCG. The amount of BDG in one vial of PCG inferred from these serum BDG levels is very similar to the actual BDG concentration in a vial of PCG. Therefore, during the administration of PCG, elevated BDG levels should be interpreted with caution, as they may be false-positive results.


Asunto(s)
Antibacterianos/administración & dosificación , Osteomielitis/tratamiento farmacológico , Penicilina G/administración & dosificación , Infecciones Neumocócicas/tratamiento farmacológico , Streptococcus pneumoniae/efectos de los fármacos , beta-Glucanos/sangre , Antibacterianos/farmacología , Reacciones Falso Positivas , Humanos , Masculino , Persona de Mediana Edad , Osteomielitis/sangre , Osteomielitis/etiología , Penicilina G/farmacología , Infecciones Neumocócicas/sangre , Infecciones Neumocócicas/complicaciones
15.
J Infect Chemother ; 24(2): 153-155, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29132926

RESUMEN

Little is known about the prevalence of ß-lactamase production in penicillin-susceptible Staphylococcus aureus isolates under high-susceptibility conditions. We analyzed S. aureus isolates with penicillin G minimum inhibitory concentration (MIC) ≤ 0.12 µg/ml that were recovered from in-/outpatients (n = 108) between 2016 and 2017 in Japan. ß-Lactamase production was detected by nitrocefin-based and Clinical and Laboratory Standards Institute penicillin zone edge testing and blaZ PCR. All isolates were categorized as having penicillin G MIC ≤0.03 µg/ml using an automated system; MICs determined based on the microdilution method were 0.016 µg/ml (2%), 0.03 µg/ml (44%), and 0.06 µg/ml (54%). Notably, no isolates harbored the blaZ gene. The results from the nitrocefin-based and zone edge tests were consistent with those obtained by PCR. S. aureus isolates with penicillin G MIC ≤0.03 µg/ml exhibited a low frequency of ß-lactamase production. Thus, screening for ß-lactamase production may be unnecessary for isolates showing such high susceptibility.


Asunto(s)
Antibacterianos/administración & dosificación , Penicilina G/administración & dosificación , Staphylococcus aureus/enzimología , beta-Lactamasas/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Japón/epidemiología , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Epidemiología Molecular , Penicilina G/uso terapéutico , Reacción en Cadena de la Polimerasa , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/epidemiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/aislamiento & purificación , Adulto Joven , beta-Lactamasas/genética
16.
J Vet Pharmacol Ther ; 41(5): 691-698, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29889313

RESUMEN

The aim of this study was to determine the intramammary dose of benzylpenicillin required to maintain a concentration in the milk above the MIC for the Gram-positive bacteria that cause mastitis. The product used in this study was a commercially available procaine benzylpenicillin in an oily suspension with micronized particles. Three dose levels were used: 200,000, 300,000, and 600,000 IU. Concentrations of benzylpenicillin in cow milk and plasma were determined after a single intramammary dose was administered into one quarter of each of the five cows in each treatment group. Samples were analyzed using an HPLC-MS/MS method, which was validated during the study. Concentrations in the milk were well above the MIC for the target pathogens for all doses tested. There was a linear dose-dependent increase in the mean AUCs of benzylpenicillin concentrations in plasma and milk. At the first milking, 12 hr after dosing, there was a significant difference between the mean milk benzylpenicillin concentrations in cows treated with a dose of 600,000 IU, and those treated with 200,000 or 300,000 IU. Although this study shows a linear relationship between the dose of procaine benzylpenicillin administered and the concentration in the milk in the healthy udder, it would be useful to conduct studies on cows with mastitis to define the optimum dose and duration of intramammary treatment with benzylpenicillin.


Asunto(s)
Antibacterianos/administración & dosificación , Glándulas Mamarias Animales/microbiología , Leche/química , Penicilina G/administración & dosificación , Animales , Antibacterianos/análisis , Antibacterianos/sangre , Bovinos , Relación Dosis-Respuesta a Droga , Femenino , Bacterias Grampositivas/efectos de los fármacos , Inyecciones/veterinaria , Glándulas Mamarias Animales/metabolismo , Penicilina G/análisis , Penicilina G/sangre
17.
Ann Dermatol Venereol ; 145(4): 278-287, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29463465

RESUMEN

INTRODUCTION: Syphilis is a sexually transmitted disease that can affect numerous organs in its secondary or tertiary stages. We describe a case of secondary syphilis with pulmonary involvement and we present a literature review. PATIENTS AND METHODS: A 69-year-old male patient was admitted to hospital for dyspnoea and extended papular exanthema with palmoplantar involvement. The serological test for syphilis was positive. Ocular examination showed bilateral papillitis and retinal haemorrhage. Chest radiography revealed an interstitial alveolar infiltrate predominantly in the upper lobes, mild pleural effusion and hilar adenopathy. These infiltrates were slightly hypermetabolic on PET scan suggesting inflammatory or infectious origin. Treatment with intravenous penicillin G was effective on cutaneous, ocular and pulmonary manifestations. DISCUSSION: Lung involvement in secondary syphilis is poorly known and rarely described. We found 27 cases of pulmonary syphilis reported in English and the main European languages since 1967. Mean age at diagnosis was 46 years with clear male predominance (89%). HIV co-infection was declared in 5 cases. Treponema pallidum was found in 6 patients using PCR on bronchoalveolar lavage (BAL) (3 patients) or on a lung biopsy (1 patient), immunohistochemistry (IHC) on BAL (1 patient) and Giemsa staining on a pleural fluid sample (1 patient). Chest X-rays may show unilateral or bilateral infiltrates or nodules with or without pleural effusion or hilar adenopathy. Sub-pleural involvement is frequent and penicillin is the treatment of choice. CONCLUSION: Pulmonary syphilitic involvement should be suspected where pulmonary symptoms or radiological changes occur in secondary syphilis. IHC, special staining or PCR on BAL, pleural fluid or lung tissue are useful for the identification of spirochetes.


Asunto(s)
Antibacterianos/administración & dosificación , Enfermedades Pulmonares Intersticiales/diagnóstico , Penicilina G/administración & dosificación , Derrame Pleural/tratamiento farmacológico , Sífilis/complicaciones , Sífilis/tratamiento farmacológico , Administración Intravenosa , Anciano , Disnea/microbiología , Exantema/microbiología , Humanos , Enfermedades Pulmonares Intersticiales/tratamiento farmacológico , Enfermedades Pulmonares Intersticiales/microbiología , Masculino , Derrame Pleural/diagnóstico , Derrame Pleural/microbiología , Hemorragia Retiniana/microbiología , Sífilis/diagnóstico , Serodiagnóstico de la Sífilis , Resultado del Tratamiento
18.
Orv Hetil ; 159(6): 234-238, 2018 Feb.
Artículo en Húngaro | MEDLINE | ID: mdl-29400103

RESUMEN

The authors present a case of neurosyphilis associated with predominant psychiatric symptoms. The elderly man was admitted because of confused behavior, maniform state, lack of critical judgement and grandiose delusions. On admission, right central facial nerve paresis, hand tremor and parkinsonism were also found. Acute brain imaging and routine laboratory tests failed to identify a firm etiology of the confusional state. The psychiatric treatment resulted in complete recovery from delirium. Afterwards, maniform psychosis dominated the clinical picture for which antipsychotics were administered. Later, rapid cognitive deterioration and progression of motor symptoms were observed. MRI revealed cortical and hippocampal atrophy and white matter hyperintensities. Lumbar puncture found pleocytosis and elevated cerebrospinal fluid protein levels. Neurosyphilis had been confirmed by serologic tests. The cognitive symptoms improved and the psychiatric symptoms remitted under penicillin treatment. Four years after diagnosis, there is a gradual progression in the cognitive decline. Two additional hospitalizations were necessary due to the relapses of psychiatric symptoms. Orv Hetil. 2018; 159(6): 234-238.


Asunto(s)
Trastornos del Conocimiento/microbiología , Neurosífilis/diagnóstico , Neurosífilis/fisiopatología , Serodiagnóstico de la Sífilis , Antibacterianos/administración & dosificación , Trastornos del Conocimiento/diagnóstico , Progresión de la Enfermedad , Estudios de Seguimiento , Humanos , Masculino , Neurosífilis/complicaciones , Neurosífilis/tratamiento farmacológico , Penicilina G/administración & dosificación
19.
Artículo en Inglés | MEDLINE | ID: mdl-28559267

RESUMEN

Rheumatic heart disease (RHD) remains an important global health challenge. Administration of benzathine penicillin (BPG) every 3 to 4 weeks is recommended as a secondary prophylaxis to prevent recurrent episodes of acute rheumatic fever and subsequent RHD. Following intramuscular injection, BPG is hydrolyzed to penicillin G (benzylpenicillin). However, little is known of the pharmacokinetics (PK) of BPG in pediatric populations at high risk of RHD or of the pharmacokinetic-pharmacodynamic relationship between penicillin exposure and clinically relevant outcomes. Dried blood spot (DBS) assays can facilitate PK studies in situations where frequent venous blood sampling is logistically difficult. A liquid chromatography-mass spectroscopy assay for penicillin G in plasma and DBS was developed and validated. Application of the DBS assay for PK studies was confirmed using samples from adult patients receiving penicillin as part of an infection management plan. The limit of quantification for penicillin G in DBS was 0.005 mg/liter. Penicillin G is stable in DBS for approximately 12 h at room temperature (22°C), 6 days at 4°C, and >1 month at -20°C. Plasma and DBS penicillin G concentrations for patients receiving BPG and penicillin G given via bolus doses correlated well and had comparable time-concentration profiles. There was poor correlation for patients receiving penicillin via continuous infusions, perhaps as a result of the presence of residual penicillin in the peripherally inserted central catheter, from which the plasma samples were collected. The present DBS penicillin G assay can be used as a surrogate for plasma concentrations to provide valid PK data for studies of BPG and other penicillin preparations developed to prevent rheumatic fever and RHD.


Asunto(s)
Antibacterianos/sangre , Pruebas con Sangre Seca/métodos , Penicilina G Benzatina/sangre , Penicilina G/sangre , Fiebre Reumática/prevención & control , Adulto , Anciano , Antibacterianos/administración & dosificación , Femenino , Humanos , Inyecciones Intramusculares , Límite de Detección , Masculino , Persona de Mediana Edad , Penicilina G/administración & dosificación , Penicilina G Benzatina/administración & dosificación , Cardiopatía Reumática/prevención & control
20.
Can Vet J ; 58(3): 289-292, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28246419

RESUMEN

A 12-year-old Norwegian Fjord gelding was diagnosed with paranasal sinusitis as a post-operative complication of tooth repulsion surgery. The infection with inspissated purulent material persisted despite sinus trephination and lavage, and systemic antimicrobial therapy. Resolution occurred following infusion of a gelatin/penicillin mixture into the right rostral and caudal maxillary sinus.


Traitement de la sinusite chronique chez un cheval à l'aide d'antimicrobiens systémiques et dans les sinus. Une sinusite paranasale a été diagnostiquée chez un hongre Fjord âgé de 12 ans comme complication postopératoire d'une chirurgie pour la répulsion d'une dent. L'infection avec du matériel purulent épaissi a persisté malgré la trépanation et le lavage du sinus et une thérapie antimicrobienne systémique. La résorption s'est produite après l'infusion d'un mélange de gélatine et de pénicilline dans les sinus maxillaires rostral et caudal droits.(Traduit par Isabelle Vallières).


Asunto(s)
Antibacterianos/administración & dosificación , Penicilina G/administración & dosificación , Complicaciones Posoperatorias/veterinaria , Sinusitis/veterinaria , Animales , Caballos , Masculino , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/microbiología , Sinusitis/tratamiento farmacológico , Extracción Dental/veterinaria , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA